Autolus Therapeutics Q1 2025 10-Q Filed
Ticker: AUTL · Form: 10-Q · Filed: May 8, 2025 · CIK: 1730463
| Field | Detail |
|---|---|
| Company | Autolus Therapeutics PLC (AUTL) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Autolus Q1 2025 10-Q is in: financials and share details updated.
AI Summary
Autolus Therapeutics plc filed its 10-Q for the period ending March 31, 2025. The company, focused on biological products, reported financial data for the first quarter of 2025. Key financial instruments and share classes, including Ordinary Shares, Deferred Class A, B, and C Shares, were detailed. The filing also included information on product-related activities for the first quarters of 2025 and 2024.
Why It Matters
This filing provides investors with the latest financial snapshot of Autolus Therapeutics, crucial for understanding their operational and financial health in early 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new disclosures.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter covered by the report.)
- 2025-05-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 2025-01-01 — Reporting Period Start Date (Marks the beginning of the financial quarter.)
Key Players & Entities
- Autolus Therapeutics plc (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Filing date
- OrdinarySharesMember (financial_instrument) — Class of shares reported
- DeferredClassASharesMember (financial_instrument) — Class of shares reported
FAQ
What is the primary business of Autolus Therapeutics plc?
Autolus Therapeutics plc is primarily involved in the biological products sector, specifically focusing on biological products (no diagnostic substances).
What is the SEC file number for Autolus Therapeutics plc?
The SEC file number for Autolus Therapeutics plc is 001-38547.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
When was Autolus Therapeutics plc incorporated or formed?
The filing indicates the company was formerly known as Autolus Therapeutics Ltd and the date of the name change was February 5, 2018.
What are the different classes of shares mentioned in the filing?
The filing mentions Ordinary Shares, Deferred Class A Shares, Deferred Class B Shares, and Deferred Class C Shares.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Autolus Therapeutics plc (AUTL).